A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/1998
10/08/1998	WO1998043555A1 Intravesical drug delivery system
10/08/1998	WO1998043497A2 Oral compositions having enhanced mouthfeel
10/08/1998	CA2285903A1 Biodegradable terephthalate polyester-poly(phosphate) polymers, compositions, articles, and methods for making and using the same
10/08/1998	CA2285591A1 Intravesical drug delivery system
10/08/1998	CA2285457A1 Method for oral delivery of proteins
10/08/1998	CA2285416A1 Polymer-modified viruses
10/08/1998	CA2285368A1 Solvent system for enhanced penetration of pharmaceutical compounds
10/08/1998	CA2285324A1 Targeted therapy to a biomedical device
10/08/1998	CA2285181A1 Drug preparations for treating sexual dysfunction
10/08/1998	CA2284896A1 Polymers with thiol terminal function
10/08/1998	CA2250106A1 Drug preferably for inhibiting inflammation
10/07/1998	EP0869117A1 Nimesulide choline salt, a process for the preparation thereof and pharmaceutical compositions containing it
10/07/1998	EP0868920A2 Hybrid protein for treatment of bladder cancer cells
10/07/1998	EP0868919A2 Aqueous suspension of loteprednol etabonate
10/07/1998	EP0868918A2 Vaccines
10/07/1998	EP0868912A2 Use of redispersible polymer powders or polymer granulates for coating pharmaceutical or agrochemical delivery forms
10/07/1998	EP0868911A2 Rapamycin formulations for oral administration
10/07/1998	EP0868910A2 Use of redispersible polymer powders or polymer granulates as binders for the preparation of solid pharmaceutical delivery forms
10/07/1998	EP0868716A1 Method for recovering data from disk with magneto-resistive head in presence of thermal asperities
10/07/1998	EP0868438A1 Selective alkylations of cyclodextrins at the levels of minimal effective basicity
10/07/1998	EP0868435A1 High efficiency tissue specific compound delivery system using streptavidin-protein a fusion protein
10/07/1998	EP0868199A1 Particle compositions
10/07/1998	EP0868198A1 FC$g(e)-PE CHIMERIC PROTEIN FOR TARGETED TREATMENT OF ALLERGY RESPONSES, A METHOD FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
10/07/1998	EP0868192A1 Fast drying, film forming iodine release solution
10/07/1998	EP0868191A1 Potentiation of complement and coagulation inhibitory properties of c1-inhibitor.
10/07/1998	EP0868190A1 Phospholipid and propylene glycol based lubricant
10/07/1998	EP0868184A1 Sustained-release microgranules containing diltiazem as the active principle
10/07/1998	EP0868183A1 Injectable quinolone formulations
10/07/1998	EP0868174A1 Oral gel capsule formulation of 1,2,4-benzotriazine oxides
10/07/1998	EP0868172A1 Direct compression carbonyl iron tablet
10/07/1998	EP0868170A1 Composition base for topical therapeutic and cosmetic preparations
10/07/1998	EP0807115A4 High molecular weight polymer-based prodrugs
10/07/1998	EP0658105B1 Local drug delivery film for periodontal treatment
10/07/1998	EP0625044B1 Compositions for nasal administration containing polar metabolites of opioid analgesics
10/07/1998	CN1195289A Pharmaceutical compositions
10/07/1998	CN1194865A Threonate possessing of partial basicity and having basic chemical structure medicine in its molecule
10/07/1998	CN1194827A Free-flowing dried particles
10/07/1998	CN1040061C Process for preparing controlled release pharmaceutical preparation
10/06/1998	US5817830 Pyrrolic compounds
10/06/1998	US5817774 Unsymmetrical complexing agents and targeting immunoreagents useful in therapeutic and diagnostic compositions and methods
10/06/1998	US5817771 Cell-targeted lytic pore-forming agents
10/06/1998	US5817699 Self-administering, sympathetic medicated and myofacial pain, parkinson's disease
10/06/1998	US5817644 Targeting of dosages of medicine and therapeutic agents
10/06/1998	US5817642 Administering mixture of chelate compound, non-steroid antiinflammatory agents, antioxidant and hyaluronic acid
10/06/1998	US5817633 Using (mono or oligo)saccharides to bind to toxins; neutralization, removal from intestines
10/06/1998	US5817632 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
10/06/1998	US5817631 Therapeutic uses of melanin
10/06/1998	US5817624 Permeation enhancer compositions for increased absorption of therapeutic proteins through the colonic membrane
10/06/1998	US5817617 Selectin and pertussis toxin derived peptides and uses thereof
10/06/1998	US5817338 Multiple unit tableted dosage form of omeprazole
10/06/1998	US5817334 Cholesterol containing phospholipid liposomes
10/06/1998	US5817332 Transdermal drug delivery system
10/06/1998	US5817328 Bioerodible implantable material and buffer
10/06/1998	US5817323 Plasticizer, starch acetate secondary matrix
10/06/1998	US5817322 Pharmaceutical base and the use of the same
10/06/1998	US5817321 Biological agent compositions
10/06/1998	US5817313 Monoclonal antibodies and conjugates thereof useful for the treatment of cancer
10/06/1998	US5817254 Mixture of water insoluble oil, emulsifiers and water
10/06/1998	CA2086631C Oral administration of immunologically active biomolecules and other therapeutic proteins
10/06/1998	CA1340071C Dectection of infectious and inflammatory lesions using anti-leukocyte conjugates
10/04/1998	CA2233797A1 Pharmaceutical product for application to uterus mucosa
10/01/1998	WO1998042876A1 Methods and compositions for using membrane-penetrating proteins to carry materials across cell membranes
10/01/1998	WO1998042745A1 Iron-casein complex and process for preparing the same
10/01/1998	WO1998042384A1 Methods for delivering bioactive agents
10/01/1998	WO1998042382A1 Pharmaceutical compositions containing propanamine derivatives and cyclodextrin
10/01/1998	WO1998042381A1 Immobilized activity stabilized lhrh antagonist complexes, method for the production thereof
10/01/1998	WO1998042379A2 Chemically and thermally stable norastemizole formulations
10/01/1998	WO1998042376A1 Composition comprising immunoglobulin
10/01/1998	WO1998042373A1 A method of preservation of vaccines with polybiguanide
10/01/1998	WO1998042368A1 Therapeutic powder formulation for pulmonary administration, containing crystalline insulin
10/01/1998	WO1998042367A1 Method for preparation of a therapeutic powder through coprecipitation of insulin and absorption enhancer
10/01/1998	WO1998042333A1 Nasal melatonin composition
10/01/1998	WO1998042321A2 Liquid compositions comprising lamivudine
10/01/1998	WO1998042318A1 Pellets having a core coated with an antifungal and a polymer
10/01/1998	WO1998042316A1 Comestible capsules having flavoured coatings
10/01/1998	WO1998042314A1 Improved dasc compositions, process for preparing same and suspensions containing same
10/01/1998	WO1998042313A1 Opthalmic non-irritating iodine medicament and method
10/01/1998	WO1998042312A2 Medicament having sclerosing activity
10/01/1998	WO1998042303A1 Cosmetic product
10/01/1998	WO1998029131A3 Aqueous glycerol formulations of somatotropin
10/01/1998	WO1998027962A3 Injectable depot gel composition and method of preparing the composition
10/01/1998	WO1998025590A3 Preparation in form of a matrix material-auxiliary agent compound containing optionally an active substance
10/01/1998	WO1998024427A3 Compositions and methods for treating or preventing inflammatory diseases
10/01/1998	WO1998016209A3 Bioceramic compositions
10/01/1998	DE19758157A1 Homogeneous anhydrous glycero-phospholipid formulation
10/01/1998	DE19713263A1 Arzneimittel, vorzugsweise zur Entzündungshemmung Drug, preferably for suppression of inflammation
10/01/1998	DE19712978A1 Chitosanmikrosphären Chitosan
10/01/1998	DE19712718A1 Immobilisierte und aktivitätsstabilisierte Komplexe von LHRH-Antagonisten und Verfahren zu deren Herstellung Immobilized and activity-stabilized complexes of LHRH antagonists and methods for their preparation
10/01/1998	DE19712708A1 Dried hydrocolloid or hydrogel based on polysaccharide(s)
10/01/1998	CA2284719A1 Nasal melatonin composition
10/01/1998	CA2284705A1 Chemically and thermally stable norastemizole formulations
10/01/1998	CA2284696A1 Opthalmic non-irritating iodine medicament and method
10/01/1998	CA2284028A1 A method of preservation of vaccines with polybiguanide
10/01/1998	CA2283965A1 Composition comprising immunoglobulin
10/01/1998	CA2282442A1 Cosmetic product
10/01/1998	CA2256599A1 Iron-casein complex and process for preparing the same
09/1998
09/30/1998	EP0867190A1 Novel toxin complex
09/30/1998	EP0867186A1 A long acting injectable parasiticidal composition and the process for its preparation
09/30/1998	EP0867181A1 Nasal melatonin composition
09/30/1998	EP0867179A1 Composition of L-DOPA esters

1 ... 1451 1452 1453 1454 1455 1456 1457 1458 1459 1460 1461 1462 1463 1464 1465 1466 1467 1468 1469 1470 1471 ... 1712